These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34526069)

  • 1. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
    Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
    J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
    Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
    J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia.
    Liu Z; Wang Y; Ding Y; Wang H; Zhang J; Wang H
    Clin Immunol; 2022 Dec; 245():109139. PubMed ID: 36184052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
    Takai Y; Misu T; Suzuki H; Takahashi T; Okada H; Tanaka S; Okita K; Sasou S; Watanabe M; Namatame C; Matsumoto Y; Ono H; Kaneko K; Nishiyama S; Kuroda H; Nakashima I; Lassmann H; Fujihara K; Itoyama Y; Aoki M
    Brain; 2021 Sep; 144(8):2401-2415. PubMed ID: 33711152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ.
    Nakajima A; Yanagimura F; Saji E; Shimizu H; Toyoshima Y; Yanagawa K; Arakawa M; Hokari M; Yokoseki A; Wakasugi T; Okamoto K; Takebayashi H; Fujii C; Itoh K; Takei YI; Ohara S; Yamada M; Takahashi H; Nishizawa M; Igarashi H; Kakita A; Onodera O; Kawachi I
    Acta Neuropathol; 2024 Apr; 147(1):76. PubMed ID: 38658413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders.
    Yick LW; Ma OK; Chan EY; Yau KX; Kwan JS; Chan KH
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36649074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice.
    Yick LW; Ma OK; Ng RC; Kwan JS; Chan KH
    Front Immunol; 2018; 9():1438. PubMed ID: 29988553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis.
    Gong Y; Zhang YL; Wang Z; Song HH; Liu YC; Lv AW; Tian LL; Zhu WL; Fu Y; Ding XL; Cui LJ; Yan YP
    J Neuroinflammation; 2020 Jun; 17(1):198. PubMed ID: 32586353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
    Brill L; Lavon I; Vaknin-Dembinsky A
    Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
    Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
    Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapeutic targets for neuromyelitis optica spectrum disorder.
    Tradtrantip L; Asavapanumas N; Verkman AS
    Expert Opin Ther Targets; 2020 Mar; 24(3):219-229. PubMed ID: 32070155
    [No Abstract]   [Full Text] [Related]  

  • 13. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
    Cotzomi E; Stathopoulos P; Lee CS; Ritchie AM; Soltys JN; Delmotte FR; Oe T; Sng J; Jiang R; Ma AK; Vander Heiden JA; Kleinstein SH; Levy M; Bennett JL; Meffre E; O'Connor KC
    Brain; 2019 Jun; 142(6):1598-1615. PubMed ID: 31056665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.
    Zhang Y; Bao Y; Qiu W; Peng L; Fang L; Xu Y; Yang H
    Exp Eye Res; 2018 Oct; 175():124-132. PubMed ID: 29913164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model.
    Jiang S; Li X; Li Y; Chang Z; Yuan M; Zhang Y; Zhu H; Xiu Y; Cong H; Yin L; Yu ZW; Fan J; He W; Shi K; Tian DC; Zhang J; Verkhratsky A; Jin WN; Shi FD
    Sci Transl Med; 2024 Feb; 16(736):eadg5116. PubMed ID: 38416841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
    Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
    J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of Angiotensin AT2-receptor stimulation in Neuromyelitis optica spectrum disorder is independent of astrocyte-derived BDNF.
    Khorooshi R; Marczynska J; Dubik M; Dieu RS; Sørensen SF; Montanana-Rosell R; Limburg HL; Tygesen C; Asgari N; Steckelings UM; Owens T
    Mult Scler Relat Disord; 2021 Aug; 53():103033. PubMed ID: 34090131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.
    Hoshino Y; Noto D; Sano S; Tomizawa Y; Yokoyama K; Hattori N; Miyake S
    J Neuroinflammation; 2022 Jan; 19(1):6. PubMed ID: 34991631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
    Furube A; Kadota T; Gochi M; Saito S; Shibata S; Inaki S; Tone K; Takagi M; Matsuno H; Araya J; Yaguchi H; Kuwano K
    Respir Investig; 2022 Sep; 60(5):684-693. PubMed ID: 35871065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
    Mader S; Jeganathan V; Arinuma Y; Fujieda Y; Dujmovic I; Drulovic J; Shimizu Y; Sakuma Y; Stern JNH; Aranow C; Mackay M; Yasuda S; Atsumi T; Hirohata S; Diamond B
    Arthritis Rheumatol; 2018 Feb; 70(2):277-286. PubMed ID: 29073350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.